A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

Nature Genetics

Volumn 13, Issue 2, 1996, Pages 210-213

  Chen, Hailei L ^a   Gabrilovich, Dmitry ^a   Tampé, Robert ^b   Girgis, Khaled R ^a   Nadaf, Sorena ^a   Carbone, David P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

ADENOSINE TRIPHOSPHATE; ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; BINDING SITES; CARCINOMA, SMALL CELL; CODON; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030043695     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0696-210     Document Type: Article

References (16)

1. Kelly, A. et al. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355, 641-644 (1992).
2. Gabathuler, R. Reid, G., Kolaitis, G., Driscoll, J. & Jefferies, W.A. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med. 180, 1415-1425 (1994).
3. Suzuki, Y., Orita, M., Shiraishi, M., Hayashi, K. & Sekiya, T.. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5, 1037-1043 (1990).
4. Walker, J.E., Saraste, M., Runswick, M.J. & Gay, N.J. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO. J. 1, 945-951 (1982).
5. Powis, S.H. et al. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenet. 37, 373-380 (1993).
6. Bodmer, H., Ogg, G., Gotch, F. & McMichael, A. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature 342, 443-446 (1989).
7. Abdel Motal, U.M., Zhou, M.X., Siddiqi, A.R. & Jondal, M. Regulation of MHC class I membrane expression by beta 2-microglobulin. Scand. J. Immunol. 38, 395-400 (1993).
8. Spies, T. & DeMars, R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351, 323-324 (1991).
9. Restifo, N.P. et al. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177, 265-272 (1993).
10. Sanda, M.G., Restifo, N.P. & Walsh, J.C. Molecular characterization of defective antigen processing in human prostate cancer. J. Natl. Cancer Inst. 86, 280-285 (1995).
11. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K.C. & Harris, A.L. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic breast cancer. Cancer Res. 56, 5191-5194 (1995).
12. de la Salle, H. et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265, 237-241 (1994).
13. Doyle, A. et al. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J. Exp. Med. 161, 1135-1151 (1985).
14. Sambrook, J., Fritsh, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory, New York. 1989).
15. Meyer, T.H., van Endert, P.M., Uebel, S., Ehring, B. & Tampe, R. Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett. 351, 443-447 (1994).
16. Bhardwaj, N. et al. Influenza Virus-infected Dendritic Cells Stimulate Strong Proliferative and Cytolytic Responses from Human CD8+ T Cells. J. Clin. Invest. 94, 797-807 (1994).